HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Alberto Culver

This article was originally published in The Rose Sheet

Executive Summary

Alberto Culver: Sales for FY 1997 (ended Sept. 30) increased 11.6% to $1.78 bil., while earnings jumped 36.1% to $85.4 mil., the company announced Oct. 23. Alberto Culver USA reported the strongest results with 18% sales growth on a 37% earning increase for the year. Sally Beauty sales rose 14%, with an identical percentage increase for earnings. The company's international business experienced only a 4% sales growth, due to negative currency translations versus the dollar, according to the firm. Earnings for the division increased 19%. The ad/promo spend for the year rose more than 20%, the company said, from $205 mil. to $255 mil. For the fourth quarter, net sales increased 5.2% to $453.4 mil., and earnings were up 15.3% to $21.8 mil. With constant exchange rates, sales would have been $10 mil. higher and earnings $1 mil. more, the company noted...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS004769

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel